ClinicalTrials.gg
RecruitingNCT07591272MDIUpdated May 15, 2026

Adaptive Dance Activities for People With Stroke

An interventional study of Movement Improvisation Skill-building and Adaptive Dance Intervention in Stroke, sponsored by Chinese University of Hong Kong. Recruiting at 1 site in Hong Kong. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-05-15.

Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Jan 2025, registered May 2026).
  • Started Jan 2025; still recruiting 1 year 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The project will investigate the effects of a novel 12-week Movement Improvisation Skill-building and Adaptive Dance Intervention (MDI) on participation, balance, mobility, balance confidence, psychological well-being, and health-related quality of life in survivors with hemiparesis.

Read the detailed description

A 2-arm, assessor-blinded, randomised controlled trial will be conducted. Individuals who are 18-80 years old and have hemiparesis after a first-ever/recurrent ischaemic/haemorrhagic stroke will be recruited. The participants will be randomly allocated to the control group receiving usual care or the intervention group receiving MDI and usual care. Based on Bandura's principles of Self-efficacy and Outcome Expectation, MDI is an online/hybrid intervention aimed to assist survivors in developing body awareness, body sense, movement improvisational skills, and abilities in creating mental images of movements and balance during their transition of care from the acute settings to home. The outcomes will be assessed before the intervention, immediately post-intervention, and 3 and 6 months post-intervention.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Stroke
  • Dance
  • Hemiparesis
  • Participation
  • Randomised controlled trial
03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's planned enrollment of 160 is above the median of 49 across 6,024 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Chinese University of Hong Kong is the lead sponsor of 1,454 studies on the registry; 474 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • a first-ever/recurrent ischaemic/haemorrhagic stroke confirmed by imaging tests,
  • receiving in-patient care at an acute stroke unit,
  • a National Institutes of Health Stroke Scale (NIHSS) total score of \<16 (mild to moderate stroke),
  • hemiparesis after stroke with the affected limb(s) scoring 1-3 on the NIHSS motor arm and/or motor leg items, respectively (drift to no effort against gravity),
  • a modified Rankin Scale (mRS) score of 2-4 (slight to moderately severe disability), and
  • a (MoCA) score of >2nd percentile.

Exclusion criteria

Exclusion Criteria:

  • ,
  • subdural or epidural haemorrhage,
  • cerebrovascular event due to brain tumour or a head injury,
  • neurologic, orthopaedic, muscular, rheumatic or vestibular condition that can interfere with participation in the intervention such as seizure or spinal injury,
  • mental condition such as depression or schizophrenia, or
  • visual or auditory impairment that cannot be corrected by visual/hearing aids.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

TIA (transient ischaemic attack)

A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.

Stroke symptoms need emergency care at once, even if they go away.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
160 participants (estimated)

Study arms

  • Experimental
    Movement Improvisation Skill-building and Adaptive Dance Intervention

    The MDI is a hybrid in-person/online intervention aimed at developing body awareness, body sense, movement improvisational skills, and the ability to create mental images of movements and balance among stroke survivors with hemiparesis.

    Other: Movement Improvisation Skill-building and Adaptive Dance Intervention

  • No intervention
    Usual care

    Usual care

Interventions

  • OtherMovement Improvisation Skill-building and Adaptive Dance Intervention

    The MDI is a hybrid in-person/online intervention aimed at developing body awareness, body sense, movement improvisational skills, and abilities in creating mental images of movements and balance among stroke survivors with hemiparesis.

06

What researchers measure

Primary outcomes

  1. Change in the level of participation in daily and social activities

    The Reintegration to Normal Living Index (Chinese version) will be used to assess participants' participation in daily and social activities.

    Time frame: From baseline to immediately, 3 months and 6 months post-intervention

Secondary outcomes

  1. Change in the level of balancing ability

    The 14-item Mini- Balance Evaluation Systems Test will be used to measure participants' anticipatory postural adjustments, reactive postural control, sensory orientation, and dynamic gait.

    Time frame: From baseline to immediately, 3 months and 6 months post-intervention

  2. Change in the level of mobility

    The 6-minute walk test (MWT) will be performed according to the American Thoracic Society guidelines.

    Time frame: From baseline to immediately, 3 months and 6 months post-intervention

  3. Change in the level of balance confidence

    The Activities-specific Balance Confidence Scale (Chinese version) will be used to assess participants' confidence in balance when performing 16 daily functional activities.

    Time frame: From baseline to immediately, 3 months and 6 months post-intervention

  4. Change in the level of psychological well-being

    Participants' emotional well-being will be measured by the Hospital Anxiety and Depression Scale (Chinese version).

    Time frame: From baseline to immediately, 3 months and 6 months post-intervention

  5. Change in the level of health-related quality of life

    The EuroQoL 5 Dimension (Chinese version) will be used. It contains 5 dimensions (mobility, self-care, usual activities, pain/ discomfort, anxiety/depression),

    Time frame: From baseline to immediately, 3 months and 6 months post-intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — The information will be provided on request.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07591272
Responsible party
Suzanne HS Lo (Associate Professor, Chinese University of Hong Kong) — Principal investigator
First posted
May 15, 2026
Start date
Jan 1, 2025
Primary completion
Dec 31, 2028 (estimated)
Completion
Dec 31, 2029 (estimated)
Last update
May 15, 2026

Study contacts

Suzanne HS Lo, PhD
Contact
suzannelo@cuhk.edu.hk
852-39434485

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion